The HIF-1α target gene EGLN1 (encoding PHD2) (Fig. 1C), which is part of the hypoxic response, was also reduced by 50% in HHT patients compared to non-HHT controls. This evidence concerns the gene HIF1A and hereditary hemorrhagic telangiectasia.